Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Julian and Felix Baker’

TRIAN PARTNERS

Billionaire Christian Leone Boosts Stake in This TV Station Operator, Nelson Peltz Lifts Stake in Struggling Pentair plc. (PNR), Plus 2 Other Moves

Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should......(read more)
Microsoft, is MSFT a good stock to buy, Bill Gates, Janicki OmniProcessor, human waste, drinking water

Bill Gates’ Cascade Investment Boosts AutoNation Inc. (AN) Stake, Buffett Keeps Buying Phillips 66 (PSX), Plus Baker Bros.’ Latest Move

According to statistics from Hedge Fund Research, the average hedge fund lost 2.76% in January, compared to a decline of approximately 5% for the S&......(read more)
Dmitry Balyasny

Hedge Funds’ Bullish Moves on Aquinox Pharmaceuticals Inc. (AQXP), Herbalife Ltd. (HLF), and Childrens Place Inc. (PLCE)

Most equity investments made by hedge funds are based on strong reasoning and comprehensive analysis, so these investment vehicles do not make blind......(read more)
Jeff Ubben VALUEACT CAPITAL

Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves

There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking......(read more)
Nathaniel August - Mangrove Partners

These 4 Stocks Were Just Bought by Baker Bros. Advisors, Clint Carlson, More

The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990. Nonetheless, approximately......(read more)
Felix Baker - Baker Bros.

A Look At Three Activist Moves By Several Elite Hedge Funds

According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared......(read more)
Barry Rosenstein JANA PARTNERS

Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company

You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......(read more)
Felix Baker - Baker Bros.

Elite Hedge Funds Making Moves in These Three Stocks

Most investors monitor hedge funds’ 13F filings in order to identify high-potential stocks, and our research has provided evidence that these public......(read more)
Jacob Gottlieb - Visium Asset Management

Baker Bros. Advisors Buys More DBV Technologies S.A. (DBVT); Visium Asset Management Goes Long On Pacira Pharmaceuticals Inc. (PCRX)

According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV......(read more)
Felix Baker - Baker Bros.

Baker Bros. Advisors Boosts Stake In Aquinox Pharmaceuticals Inc. (AQXP) to 39.8% Before Its Jump

Julian and Felix Baker’s Baker Bros. Advisors LP has filed a 13D filing in which it reported ownership of 4.27 million shares of Aquinox Pharmaceuticals......(read more)
Broadfin Kevin Kotler

Kevin Kotler, Broadfin Capital Increase Holding Of Progenics Pharmaceuticals, Inc. (PGNX)

Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fund’s investment in the stock. Kotler’......(read more)
MEI Pharma

Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%

Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares......(read more)